Privacy Policy Banner

We use cookies to improve your experience. By continuing, you agree to our Privacy Policy.

Stock Exchange: Bye-bye Warren, rumor on Shell and BP, an Orange DG at Eutelsat

Stock Exchange: Bye-bye Warren, rumor on Shell and BP, an Orange DG at Eutelsat
Stock Exchange: Bye-bye Warren, rumor on Shell and BP, an Orange DG at Eutelsat

Large maneuvers resume in , with an operation between Santander and Erste in in the bank or rumors of Shell for BP. The CEO of Orange France leaves for Eutelsat and Microsoft becomes the capitalization.

In France

Important ads (and less important … I specify that the information is given hot before opening and does not prejudge the color of the actions during the session)

  • Orange makes several nominations, including that of Jérôme Hénique as CEO of Orange France.
  • The AMF rebounds again the OPRs launched by Bolloré on Cambodia Company, Financial Moncey and Industrial and Financial Society of Artois.

  • Eutelsat appoints Jean-François Fallacher as DG.
  • Econocom achieves a private Schuldschein type placement of € 225 million.
  • The Mother house of Altamir offers a simplified OPA at 28.50 EUR action.

  • Waga associates with Scapigliato to produce biomethane in Tuscany.
  • Inventiva obtains the second tranche of € 116 million in its structured financing in a maximum amount of € 348 million.
  • The phaxiam will be struck off on the side regardless of the content of the user offers at the court bar.

  • TME Pharma changes CEO and says it is “confident in obtaining non -dilutive financing to short -term operational needs”.
  • Hopium confirms the performance of its 200 kW system on a test bench.
  • Nanobiotix presents the complete results of the phase 1 study in pancreatic cancer.
  • The main publications of the : Elis, Rubis, Coface, Coil … the rest here.

In the vast world

Important ads (and less important)

D’Europe

North America

Of Pacific Asia and elsewhere

The rest of the global publication agenda here.

Lectures

-

PREV financing the rehabilitation of refineries under investigation
NEXT The Quebec CHU was wrong: Chinese compotes will remain on sale in its hospitals